
|Articles|December 1, 2007
Supplements and Featured Publications
- Decision Maker News - Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia an
- Volume 12
- Issue 1 - Decis
Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Pembrolizumab Plus Enfortumab Vedotin for MIBC
2
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
3
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
4
Trial Data Yield Risk-Based NRSTS Treatment Strategies
5















































